Taiwanese Pharmaceuticals & Biotech Low Leverage High Rewards

PharmaEngine

Market Cap: NT$10.4b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.7b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

Syngen BiotechLtd

Market Cap: NT$3.2b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.

Chi Sheng Pharma & Biotech

Market Cap: NT$1.7b

Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.

TTY Biopharm

Market Cap: NT$20.2b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

TSH Biopharm

Market Cap: NT$2.1b

Develops and markets pharmaceutical products in Taiwan.

Sunmax Biotechnology

Market Cap: NT$21.6b

A biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China.

Sinphar PharmaceuticalLtd

Market Cap: NT$5.8b

Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

SYN-TECH Chem. & Pharm

Market Cap: NT$3.2b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.